Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
<3
General Information
Revision date
2005-05-26
Product name
"MINLON" MINERAL REINFORCED NYLON RESINS ON SYNONYM LIST MIN001
Product name
"MINLON" MINERAL REINFORCED NYLON RESINS ON SYNONYM LIST MIN001
Identification on the label/Trade name
"MINLON"
Emergency telephone
1- (800) -441-3637
Icons in SDS
Company Information
company name
DuPont Engineering Polymers
Section 2
SECTION 2: Hazards identification
Potential health effects
ADDITIONAL HEALTH EFFECTS Read "MINLON" Molding Guide before using this product. POLYHEXAMETHYLENE ADIPAMIDE (Nylon 66) In general, skin irritation has not been produced in human patch ee tests with Nylon 66. However, a small percentage of subjects may t respond to prolonged contact with redness of skin. Significant skin permeation, and systemic toxicity, after contact appears unlikely. There are no reports of human sensitization. If particles of Nylon 66 contact the eye, mechanical irritation with tearing, pain or blurred vision may result. Carbon Black Immediate effects of overexposure to Carbon Black by inhalation may include irritation of the nose, throat, and lungs with cough, difficulty breathing or shortness of breath. If particles from Carbon Black contact the eye, mechanical irritation with tearing, pain or blurred vision may result. Significant skin permeation, and systemic toxicity, after contact with Carbon Black appears unlikely. There are no reports of human sensitization. Epidemiologic studies demonstrate no significant risk of human cancer from exposure to Carbon Black. While some reports cite an increased incidence of pulmonary abnormalities, such as decreased pulmonary function and radiological changes among Carbon Black workers, other reports show no correlation between exposure and (Continued) w MINOO1 Page 2 continued) Ts * . effects on pulmonary function or disease. Increased susceptibility to the effects of Carbon Black may be observed in persons with pre-existing disease of the lungs. TITANIUM DIOXIDE Short-term overexposure by inhalation to Titanium Dioxide may cause irritation of nose, throat, and lungs with cough, difficulty breathing or shortness of breath. Repeated skin contact with Titanium Dioxide may cause drying or cracking of the skin in sensitive individuals. Eye contact with Titanium Dioxide may cause eye irritation with tearing, pain or blurred vision. Results of a DuPont epidemiology study showed that employees who had been exposed to Titanium Dioxide were at no greater risk of developing lung cancer than were employees who had not been exposed to Titanium Dioxide. No pulmonary fibrosis was found in any of the employees and no association was observed between Titanium Dioxide exposure and chronic respiratory disease or x-ray abnormalities. Based on the results of this study, DuPont concludes that Titanium Dioxide will not cause lung cancer or chronic respiratory disease in humans at concentrations experienced in the workplace. Carcinogenicity Information The following components are listed by IARC, NTP,